P
CLMT icon

&Partners’s Calumet Specialty Products CLMT Stock Holding History

&Partners’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-16,240
Closed -$59K – 153
2019
Q4 		$59K Hold
16,240
– – 0.07% 155
2019
Q3 		$59K Sell
16,240
-3,975
-20% -$17K 0.08% 149
2019
Q2 		$85K Hold
20,215
– – 0.12% 137
2019
Q1 		$72K Sell
20,215
-9,650
-32% -$32.1K 0.1% 133
2018
Q4 		$56K Buy
+29,865
New +$123K 0.09% 128

Other funds holding CLMT

AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BC
Barnett & Company Chattanooga, Tennessee $129M AUM 14.9% 1-Year Est. Return
SCM
Springhouse Capital Management Westport, Connecticut $55.3M AUM 20.84% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WWM
Windsor Wealth Management Indianapolis, Indiana $546M AUM 16.47% 1-Year Est. Return

&Partners's CLMT Position: Q1 2020 in Review

&Partners sold out of Calumet Specialty Products (CLMT) in Q1 2020, closing a stake of 16,240 shares — an estimated $59K sold.

&Partners first reported a position in CLMT in Q4 2018 and held it in 5 quarters. The position peaked at $85K in Q2 2019. 49 funds tracked by Wall St. Rank hold CLMT as of Q1 2020.

  • &Partners reported no remaining Calumet Specialty Products position as of Q1 2020 after selling out during the quarter.
  • &Partners sold 16,240 Calumet Specialty Products shares in Q1 2020, an estimated $59K.
  • &Partners first reported a position in Calumet Specialty Products in Q4 2018 and held it in 5 quarters.
  • &Partners's Calumet Specialty Products position peaked at $85K in Q2 2019.
  • 49 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2020.

Based on &Partners's 13F filing for Q1 2020, filed 3 Apr 2020.